バイオサージェリーの世界市場レポート 2025年

バイオサージェリー市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.7％で229億8,000万米ドルに成長します。予測期間の成長は、組織工学の進歩、低侵襲手術の増加、再生医療への注力、生物製剤へのシフト、高齢化社会のニーズなどに起因すると考えられます。予測期間における主な動向としては、低侵襲手術の増加、美容整形手術の増加、幹細胞治療への注目、創傷治療の進歩、生分解性製品の開発などが挙げられます。

バイオサージェリー市場は、主に慢性疾患の有病率の増加によって成長する見込みです。慢性疾患は1年以上続き、継続的な医療を必要とするため、個人の健康に大きな影響を与え、日常生活を制限します。米国では、糖尿病、がん、心臓病などの慢性疾患が死亡や身体障害の主な原因となっています。バイオサージェリーは、死滅した組織を除去し、感染リスクを低減し、治癒プロセスを促進することにより、慢性創傷の管理に重要な役割を果たしています。例えば、2022年3月にオーストラリア統計局が発表したところによると、オーストラリア人の78.6％が少なくとも1つの慢性疾患に罹患しており、人口の半数以上が罹患しています。慢性疾患の増加は、バイオサージェリー市場の成長を促進する重要な要因です。

バイオサージェリー市場の成長に寄与する重要な要因は、事故件数の増加です。日常生活、職場、交通機関、スポーツなどさまざまな場面で、不測の事態による危害や傷害が発生します。バイオサージェリーは、外傷性状況、怪我、外科手術において、出血を緩和し、効果的な凝固を促進し、創傷治癒を促進するために事故シナリオで利用されます。2022年、オーストラリアのインフラ・運輸・地域開発・通信省は1,194件の交通死亡事故を報告し、前年比5.8％増となった。事故件数の増加が、効果的な創傷管理のためのバイオサージェリーの採用を後押ししています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界バイオサージェリーPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界のバイオサージェリー市場：成長率分析
• 世界のバイオサージェリー市場の実績：規模と成長, 2019-2024
• 世界のバイオサージェリー市場の予測：規模と成長, 2024-2029, 2034F
• 世界バイオサージェリー総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバイオサージェリー市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 骨移植代替品
• 軟部組織付着部
• 止血剤
• 外科用シーラントおよび接着剤
• 癒着防止バリア
• ステープルライン補強
• 世界のバイオサージェリー市場：ソース別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 天然または生物由来製品
• 合成製品
• 世界のバイオサージェリー市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 整形外科
• 一般外科
• 神経外科
• 心臓血管外科
• 婦人科手術
• その他の用途
• 世界のバイオサージェリー市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• その他のエンドユーザー
• 世界のバイオサージェリー市場、骨移植代替品の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 人工骨移植
• 天然骨移植
• 世界のバイオサージェリー市場軟部組織付着部のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• メッシュ製品
• 生物学的移植
• 世界のバイオサージェリー市場、止血剤の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 粉末剤
• ゲルベースの薬剤
• 世界のバイオサージェリー市場、外科用シーラントおよび接着剤の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• フィブリンシーラント
• 合成シーラント
• 世界のバイオサージェリー市場、癒着防止バリアのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 吸収性バリア
• 非吸収性バリア
• 世界のバイオサージェリー市場、ステープルライン補強のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 強化装置
• 外科用ステープル

第7章 地域別・国別分析

• 世界のバイオサージェリー市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のバイオサージェリー市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオサージェリー市場：競合情勢
• バイオサージェリー市場：企業プロファイル
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • B. Braun SE Overview, Products and Services, Strategy and Financial Analysis
  • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • Hemostasis LLC Overview, Products and Services, Strategy and Financial Analysis
  • Integra LifeSciences Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Johnson & Johnson Services Inc.
• CryoLife Inc.
• CSL Limited
• Pfizer Inc.
• Zimmer Biomet Holdings Inc.
• Kuros Biosciences AG
• Orthofix Medical Inc.
• Smiths & Nephew plc
• Medtronic plc
• Stryker Corp.
• Betatech Medical
• Tissue Regenix Group plc
• Aroa Biosurgery Ltd.
• Anika Therapeutics Inc.
• Arthrex Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• バイオサージェリー市場2029：新たな機会を提供する国
• バイオサージェリー市場2029：新たな機会を提供するセグメント
• バイオサージェリー市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Biosurgery involves utilizing live maggots to remove dead tissue, minimize infection risks, and accelerate wound healing. This field encompasses semi-synthetic, synthetic, or natural materials that aid in the recuperation of surgical incisions and tissue regeneration.

Primary biosurgery products include bone-graft substitutes, soft-tissue attachments, hemostatic agents, surgical sealants and adhesives, adhesion barriers, and staple line reinforcement. Bone graft substitutes are materials, natural or synthetic, used to fill bone voids and facilitate bone mending. These products stem from natural or biological sources as well as synthetic origins. They find application in orthopedic, general, neurological, cardiovascular, gynecological surgeries, and others, catering to end-users such as hospitals, clinics, and similar facilities.

The biosurgery market research report is one of a series of new reports from The Business Research Company that provides biosurgery market statistics, including biosurgery industry global market size, regional shares, competitors with a biosurgery market share, detailed biosurgery market segments, market trends and opportunities, and any further data you may need to thrive in the biosurgery industry. This biosurgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biosurgery market size has grown strongly in recent years. It will grow from $15.27 billion in 2024 to $16.49 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to increasing surgical procedures, rise in chronic diseases, growing geriatric population, shift towards biodegradable product, regulatory changes, and approvals.

The biosurgery market size is expected to see strong growth in the next few years. It will grow to $22.98 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to advancements in tissue engineering, rise in minimally invasive procedures, focus on regenerative medicine, shift towards biologics, aging population needs. Major trends in the forecast period include growth in minimally invasive procedures, rise in cosmetic and plastic surgeries, focus on stem cell therapies, advancements in wound care, development of biodegradable products.

The biosurgery market is poised for growth, primarily driven by the increasing prevalence of chronic diseases. Chronic diseases, lasting for a year or longer and requiring ongoing medical care, significantly impact individuals' health, restricting daily activities. In the U.S., chronic diseases such as diabetes, cancer, and heart disease are leading causes of death and disability. Biosurgery plays a crucial role in managing chronic wounds by eliminating dead tissue, reducing infection risk, and expediting the healing process. For example, in March 2022, the Australian Bureau of Statistics reported that 78.6% of Australians suffered from at least one chronic illness, affecting over half of the population. The rise in chronic diseases is a key factor propelling the growth of the biosurgery market.

A significant factor contributing to the growth of the biosurgery market is the increase in the number of accidents. Accidents, unforeseen events causing harm or injury, occur in various settings such as daily life, workplaces, transportation, and sports. Biosurgery is utilized in accident scenarios to mitigate blood loss, facilitate effective coagulation, and promote wound healing in traumatic situations, injuries, or surgical operations. In 2022, the Department of Infrastructure, Transport, Regional Development, and Communications in Australia reported 1,194 fatal traffic accidents, indicating a 5.8% increase over the previous year. The growth in accident numbers is driving the adoption of biosurgery for effective wound management.

Major companies in the biosurgery market are utilizing technological advancements, particularly in advanced wound care technology, to improve healing outcomes, reduce infection rates, and enhance patient recovery times through innovative products and techniques. Advanced wound care technology includes cutting-edge methods and products aimed at promoting wound healing, preventing infections, and improving overall patient outcomes. For example, in September 2024, Health Care at Home India Pvt Ltd, an India-based manufacturer of medical products, launched the WOW (Warriors of Woundcare) Nurses initiative. This program aims to proactively prevent and treat bedsores, which are common complications for patients with limited mobility. Bedsores can significantly impede recovery, prolong hospital stays, and increase the risk of infections.

Prominent companies in the biosurgery market are increasingly adopting a strategic partnership approach to enhance their capabilities and expand their market presence. Strategic partnerships involve leveraging the strengths and resources of collaborating companies for mutual benefits and success. In a notable example, Biocomposites Ltd., a UK-based manufacturing company specializing in calcium compound solutions for bone and soft tissue regeneration and repair, entered into an agreement with Zimmer Biomet Holdings Inc. in March 2022. Under this agreement, Biocomposites exclusively sells genex Bone Graft Substitute in the US orthopedic market. Genex Bone Graft Substitute is a biphasic composite with excellent purity, precisely developed to balance osteoconductive scaffold toughness and persistence in the body, facilitating optimal bone architecture rebuilding. The partnership includes enhancements for the US market, incorporating a new closed-mixing method to save preparation time and extend working time. It also offers a broader range of delivery options, enabling surgeons to inject, shape, or prepare beads according to their preferred approach.

In June 2022, GTCR LLC, a US-based private equity firm, acquired Barron Precision Instruments, LLC, for an undisclosed amount. This acquisition is part of GTCR LLC's strategy to drive growth and enhance operations within Barron Precision Instruments. Barron Precision Instruments, LLC, is a US-based manufacturer known for producing high-quality medical instruments.

Major companies operating in the biosurgery market include Baxter International Inc., B. Braun SE, Becton, Dickinson and Company, Hemostasis LLC, Integra LifeSciences Corporation, Johnson & Johnson Services Inc., CryoLife Inc., CSL Limited, Pfizer Inc., Zimmer Biomet Holdings Inc., Kuros Biosciences AG, Orthofix Medical Inc., Smiths & Nephew plc, Medtronic plc, Stryker Corp., Betatech Medical, Tissue Regenix Group plc, Aroa Biosurgery Ltd., Anika Therapeutics Inc., Arthrex Inc., B Braun Surgical SA, Biom'Up SA, Boston Scientific Corporation, Coloplast Corp., Cook Medical Inc., Endo International plc, Genzyme Corporation, Takeda Pharmaceutical Company Limited, Cerus Corporation

North America was the largest region in the biosurgery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the biosurgery market report during the forecast period. The regions covered in the biosurgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biosurgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biosurgery market consists of revenues earned by entities by providing biosurgery services such as maggot therapy, transplantation, and autologous chondrocyte implantation. The market value includes the value of related goods sold by the service provider or included within the service offering. The biosurgery market also includes sales of absorbable hemostats and surgical sealants which are used in providing biosurgery services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biosurgery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biosurgery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biosurgery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biosurgery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Bone-Graft Substitutes; Soft-Tissue Attachments; Hemostatic Agents; Surgical Sealants And Adhesives; Adhesion Barriers; Staple Line Reinforcement
• 2) By Source: Natural Or Biologics Products; Synthetic Products
• 3) By Application: Orthopedic Surgery; General Surgery; Neurological Surgery; Cardiovascular Surgery; Gynecological Surgery; Other Applications
• 4) By End-User: Hospitals; Clinics; Other End-Users

Subsegments;

• 1) By Bone-Graft Substitutes: Synthetic Bone Grafts; Natural Bone Grafts
• 2) By Soft-Tissue Attachments: Mesh Products; Biological Grafts
• 3) By Hemostatic Agents: Powdered Agents; Gel-based Agents
• 4) By Surgical Sealants And Adhesives: Fibrin Sealants; Synthetic Sealants
• 5) By Adhesion Barriers: Absorbable Barriers; Non-absorbable Barriers
• 6) By Staple Line Reinforcement: Reinforcement Devices; Surgical Staples
• Companies Mentioned: Baxter International Inc.; B. Braun SE; Becton, Dickinson and Company; Hemostasis LLC; Integra LifeSciences Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biosurgery Market Characteristics

3. Biosurgery Market Trends And Strategies

4. Biosurgery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Biosurgery Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biosurgery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biosurgery Market Growth Rate Analysis
• 5.4. Global Biosurgery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biosurgery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biosurgery Total Addressable Market (TAM)

6. Biosurgery Market Segmentation

• 6.1. Global Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bone-Graft Substitutes
• Soft-Tissue Attachments
• Hemostatic Agents
• Surgical Sealants and Adhesives
• Adhesion Barriers
• Staple Line Reinforcement
• 6.2. Global Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural or Biologics Products
• Synthetic Products
• 6.3. Global Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Gynecological Surgery
• Other Applications
• 6.4. Global Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Other End-Users
• 6.5. Global Biosurgery Market, Sub-Segmentation Of Bone-Graft Substitutes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synthetic Bone Grafts
• Natural Bone Grafts
• 6.6. Global Biosurgery Market, Sub-Segmentation Of Soft-Tissue Attachments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mesh Products
• Biological Grafts
• 6.7. Global Biosurgery Market, Sub-Segmentation Of Hemostatic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Powdered Agents
• Gel-based Agents
• 6.8. Global Biosurgery Market, Sub-Segmentation Of Surgical Sealants And Adhesives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fibrin Sealants
• Synthetic Sealants
• 6.9. Global Biosurgery Market, Sub-Segmentation Of Adhesion Barriers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Absorbable Barriers
• Non-absorbable Barriers
• 6.10. Global Biosurgery Market, Sub-Segmentation Of Staple Line Reinforcement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reinforcement Devices
• Surgical Staples

7. Biosurgery Market Regional And Country Analysis

• 7.1. Global Biosurgery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biosurgery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biosurgery Market

• 8.1. Asia-Pacific Biosurgery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biosurgery Market

• 9.1. China Biosurgery Market Overview
• 9.2. China Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biosurgery Market

• 10.1. India Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biosurgery Market

• 11.1. Japan Biosurgery Market Overview
• 11.2. Japan Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biosurgery Market

• 12.1. Australia Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biosurgery Market

• 13.1. Indonesia Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biosurgery Market

• 14.1. South Korea Biosurgery Market Overview
• 14.2. South Korea Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biosurgery Market

• 15.1. Western Europe Biosurgery Market Overview
• 15.2. Western Europe Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biosurgery Market

• 16.1. UK Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biosurgery Market

• 17.1. Germany Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biosurgery Market

• 18.1. France Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biosurgery Market

• 19.1. Italy Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biosurgery Market

• 20.1. Spain Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biosurgery Market

• 21.1. Eastern Europe Biosurgery Market Overview
• 21.2. Eastern Europe Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biosurgery Market

• 22.1. Russia Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biosurgery Market

• 23.1. North America Biosurgery Market Overview
• 23.2. North America Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biosurgery Market

• 24.1. USA Biosurgery Market Overview
• 24.2. USA Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biosurgery Market

• 25.1. Canada Biosurgery Market Overview
• 25.2. Canada Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biosurgery Market

• 26.1. South America Biosurgery Market Overview
• 26.2. South America Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biosurgery Market

• 27.1. Brazil Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biosurgery Market

• 28.1. Middle East Biosurgery Market Overview
• 28.2. Middle East Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biosurgery Market

• 29.1. Africa Biosurgery Market Overview
• 29.2. Africa Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biosurgery Market Competitive Landscape And Company Profiles

• 30.1. Biosurgery Market Competitive Landscape
• 30.2. Biosurgery Market Company Profiles
  • 30.2.1. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. B. Braun SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Hemostasis LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Integra LifeSciences Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Biosurgery Market Other Major And Innovative Companies

• 31.1. Johnson & Johnson Services Inc.
• 31.2. CryoLife Inc.
• 31.3. CSL Limited
• 31.4. Pfizer Inc.
• 31.5. Zimmer Biomet Holdings Inc.
• 31.6. Kuros Biosciences AG
• 31.7. Orthofix Medical Inc.
• 31.8. Smiths & Nephew plc
• 31.9. Medtronic plc
• 31.10. Stryker Corp.
• 31.11. Betatech Medical
• 31.12. Tissue Regenix Group plc
• 31.13. Aroa Biosurgery Ltd.
• 31.14. Anika Therapeutics Inc.
• 31.15. Arthrex Inc.

32. Global Biosurgery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biosurgery Market

34. Recent Developments In The Biosurgery Market

35. Biosurgery Market High Potential Countries, Segments and Strategies

• 35.1 Biosurgery Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biosurgery Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biosurgery Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer